The FAIRPlus proposal, coordinated by ELIXIR, has just passed stage two review and invited into contract negotiations. The project proposal was submitted to the Innovative Medicines Initiative (IMI), and will see ELIXIR Nodes and other academic partners supporting EFPIA companies and specific IMI projects in making their data FAIR: Findable, Accessible, Interoperable and Re-usable. The following ELIXIR Nodes are involved as partners: ELIXIR Spain, ELIXIR Netherlands, ELIXIR UK, ELIXIR Luxembourg, ELIXIR Switzerland and EBI. IMIM takes part in the project through the the Integrative Biomedical Informatics Group of the GRIB led by Laura I. Furlong and Ferran Sanz.
ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publicly funded research. It coordinates, integrates and sustains bioinformatics resources across its member states and enables users in academia and industry to access services that are vital for their research. More information about ELIXIR.